Rss Feed

Findings suggest that impaired fiber metabolism in celiac disease is due to microbial deficits, not just diet, emphasizing the need for targeted interventions.

The AHA's dietary guidance emphasizes food choices over fad diets to reduce heart disease risk and improve cardiovascular health across all life stages.

NICE has recommended Wegovy® (semaglutide injection) 2.4 mg as the first GLP-1 RA to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight (BMI ≥ 27 kg/m2).

Lifestyle-behavioral factors and socioeconomic status play an important role in shaping healthy ageing, but their effects may differ depending on your DNA, according to a new international study led by Adelaide University researchers.

When a person reaches across a table to pass the salt, their brain is doing something far more complex than recognizing a request and executing a movement.

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer's Disease, or AI4AD. The new $12.6 million award to advance the project's next phase, AI4AD2, brings its total investment in AI4AD to $30.7 million.

A new map of a brain circuit specific to chronic pain suggests a promising route to treatment for the roughly 60 million Americans living with persistent pain, according to a study published in Nature.

Vaccine uptake data has been examined to assess the impact of moving from a '2+1' to a '1+1' Pneumococcal Conjugate Vaccine (PCV) dose schedule on vaccine coverage and health inequalities among infants in England.

In a study of U.S. adults, walking was, by far, the most popular leisure-time physical activity, while rural residents also enjoyed gardening, hunting and fishing, and urban residents more commonly reported running, weightlifting and dance. Urban residents were more likely than rural residents to meet physical activity guidelines.

People with long COVID are at increased risk of developing cardiovascular disease, according to a new study from Karolinska Institutet published in eClinicalMedicine.

Shisha smoking continues to be overlooked as a public health issue in the UK, argue experts in The BMJ today.

The Icahn School of Medicine at Mount Sinai today announced the enrollment of its first patient in a U.S. Department of Defense-funded pivotal clinical trial to evaluate whether a fast-acting, drug-free brain stimulation therapy can safely and quickly relieve symptoms of postpartum depression.

​Being unable to afford dental care may increase a person's risk of developing cardiovascular disease or dementia, according to a new study led by researchers at Boston University School of Public Health (BUSPH).

Exposure to extreme heat conditions is resulting in more babies being born with low birth weight, according to a new study involving Adelaide University researchers.

Working with "digital twins" of patients' hearts, doctors improved cardiac ablation outcomes for patients with life-threatening arrythmias.

A UTHealth Houston physician's visit to a local public health building sparked community awareness and inspired a new research idea.

Having higher levels of vitamin D in the blood in middle age is associated with lower levels of tau protein in the brain, which is a sign of dementia, years later, according to a study published April 1, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology.

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a study published on April 1, 2026, in Neurology® Open Access, an official journal of the American Academy of Neurology.

A team of researchers from NYU Abu Dhabi and the University of Denver have identified a promising small molecule that could help slow or halt the progression of serious brain diseases such as Parkinson's disease, offering new hope for treatments that go beyond managing symptoms.

Cholera-causing bacteria are locked in an evolutionary arms race with a viral nemesis, according to a new genomic study.